Cardiologists Debate New Blood Pressure Guidelines
New, stricter blood pressure guidelines have sparked concern and debate among cardiologists. Critics worry the new standards could lead to overdiagnosis of hypertension and subsequent overtreatment of patients who may not require medical intervention.
- The latest guidelines, released in August 2025 by the American Heart Association and the American College of Cardiology, are the first update since 2017. - The universal treatment target for all adults with high blood pressure is now recommended to be below 130/80 mmHg. - For individuals with Stage 1 hypertension (130-139/80-89 mm Hg) who are otherwise at low risk, lifestyle modifications are recommended for three to six months before starting medication. - Patients with Stage 2 hypertension, defined as a blood pressure of 140/90 mm Hg or higher, are now advised to begin treatment with two different antihypertensive medications simultaneously, ideally in a single combination pill. - The updated guidelines place a new emphasis on the link between blood pressure and brain health, stating that lowering blood pressure can reduce the risk of dementia by 12% to 19%. - A minimally invasive catheter-based procedure called renal denervation, which received FDA approval in November 2023, is now included as a treatment option for patients with resistant hypertension. - The guidelines now recommend screening all patients with high blood pressure for primary aldosteronism, a hormonal condition that is now considered a more common and often overlooked cause of hypertension. - For pregnant individuals with chronic hypertension, the new guidelines recommend starting medication when blood pressure reaches 140/90 mm Hg or higher to reduce the risk of serious complications.
